Medanta Introduces AI-Driven Catheter for Advanced Pulmonary Embolism Treatment

Medanta, claims to be the first hospital in India to adopt this technology. It said, it has treated 25 cases of pulmonary embolism since July 2023. Utilising AI, this technology minimises blood loss, reducing complications and expediting patient recovery.

Medanta Hospital has introduced the Penumbra Lightning 12 F Catheter, an AI-driven device transforming selective clot removal in endovascular procedures.

Medanta claims to be the first hospital in India to adopt this technology. As per the hospital, it has treated 25 cases of pulmonary embolism since July 2023. Utilising AI, this technology minimises blood loss, reducing complications and expediting patient recovery.

The initial patient, a 62-year-old man with severe deep vein thrombosis and a non-obstructive clot in the left lung lobe, experienced sudden leg pain and swelling. Using the Penumbra Lightning 12 F catheter, the clots were efficiently removed, providing immediate relief. The patient was discharged within two days with follow-up treatment instructions, as shared by the hospital.

Highlighting the significance of this advancement, Dr Naresh Trehan, chairman and managing director at Medanta, said, "The introduction of this technology marks a notable step forward in aiding individuals with pulmonary embolism, enabling faster recovery and improved outcomes."

To raise awareness, Medanta initiated the PEiRT (Pulmonary Embolism Interventions and Response Team) program, focusing on reducing the incidence of pulmonary embolism in India.

The Penumbra Lightning technology ensures quicker rehabilitation, reduces complications and improves overall recovery time compared to traditional procedures.

To promote best practices, Medanta Gurugram's Division of Vascular & Endovascular Sciences organised a conference themed 'Pulmonary Embolism: What is known & what we need to know – State-of-the-art treatment and scientific updates.

Previously, in August, Medanta Gurugram had collaborated with GE Healthcare to launch Tele-ICU services nationwide.

This initiative addresses the shortage of critical care specialists in India, particularly in remote areas, by allowing specialists to monitor and manage ICU patients remotely, ultimately improving patient outcomes and reducing mortality rates.

Apart from Tele-ICU, Medanta has also launched several other healthcare technology initiatives in recent years. For example, it has introduced a mobile app 'Medanta eClinic', for patients to access medical records, book appointments, and consult with doctors remotely.

Medanta also has deployed robots in the hospital to assist with patient care and infection control. In addition, they have collaborated with IBM to use artificial intelligence and machine learning to predict and prevent cardiac diseases.